Neurometrix Stock Price on December 11, 2024
If you're considering investing in NeuroMetrix Stock, it is important to understand the factors that can impact its price. NeuroMetrix has Sharpe Ratio of -0.0133, which conveys that the firm had a -0.0133% return per unit of risk over the last 3 months. NeuroMetrix exposes zero different technical indicators, which can help you to evaluate volatility embedded in its price movement.
NeuroMetrix Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
NeuroMetrix |
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| NURO |
Based on monthly moving average NeuroMetrix is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NeuroMetrix by adding NeuroMetrix to a well-diversified portfolio.
NeuroMetrix Valuation on December 11, 2024
It is possible to determine the worth of NeuroMetrix on a given historical date. On December 11, 2024 NeuroMetrix was worth 4.0 at the beginning of the trading date compared to the closed value of 4.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of NeuroMetrix stock. Still, in general, we apply an absolute valuation method to find NeuroMetrix's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of NeuroMetrix where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against NeuroMetrix's related companies.
| Open | High | Low | Close | Volume | |
| 4.15 | 4.15 | 4.02 | 4.03 | 1,883 | |
12/11/2024 | 4.00 | 4.00 | 3.83 | 4.00 | 8,087 |
| 3.90 | 3.90 | 3.88 | 3.90 | 2,644 |
| Backtest NeuroMetrix | | | NeuroMetrix History | | | NeuroMetrix Valuation | Previous | Next |
NeuroMetrix Trading Date Momentum on December 11, 2024
| On December 12 2024 NeuroMetrix was traded for 3.90 at the closing time. The top price for the day was 3.90 and the lowest listed price was 3.88 . The trading volume for the day was 2.6 K. The trading history from December 12, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 2.50% . The trading delta at closing time against the current closing price is 3.75% . |
NeuroMetrix Fundamentals Correlations and Trends
By evaluating NeuroMetrix's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among NeuroMetrix's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. NeuroMetrix financial account trend analysis is a perfect complement when working with valuation or volatility modules.About NeuroMetrix Stock history
NeuroMetrix investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NeuroMetrix is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NeuroMetrix will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NeuroMetrix stock prices may prove useful in developing a viable investing in NeuroMetrix
NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts. Neurometrix operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 23 people.
NeuroMetrix Stock Technical Analysis
NeuroMetrix technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
NeuroMetrix Period Price Range
Low | December 30, 2024
| High |
0.00 | 0.00 |
NeuroMetrix cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
NeuroMetrix December 30, 2024 Market Strength
Market strength indicators help investors to evaluate how NeuroMetrix stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NeuroMetrix shares will generate the highest return on investment. By undertsting and applying NeuroMetrix stock market strength indicators, traders can identify NeuroMetrix entry and exit signals to maximize returns
NeuroMetrix Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for NeuroMetrix's price direction in advance. Along with the technical and fundamental analysis of NeuroMetrix Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NeuroMetrix to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.05) | |||
| Total Risk Alpha | (0.14) | |||
| Treynor Ratio | 1.03 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeuroMetrix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Medical Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeuroMetrix. If investors know NeuroMetrix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeuroMetrix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of NeuroMetrix is measured differently than its book value, which is the value of NeuroMetrix that is recorded on the company's balance sheet. Investors also form their own opinion of NeuroMetrix's value that differs from its market value or its book value, called intrinsic value, which is NeuroMetrix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeuroMetrix's market value can be influenced by many factors that don't directly affect NeuroMetrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeuroMetrix's value and its price as these two are different measures arrived at by different means. Investors typically determine if NeuroMetrix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeuroMetrix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.